Table 2.

Predictors of Adherence to Aspirin after Acute Coronary Syndromes (N=169)^*

Characteristic	Model 1 Beta (SE)	P-value	Model 2a Odds Ratio Beta (SE)	P-value	Model 2b Beta (SE)	P-value	Model 2c Beta (SE)	P-value	Model 2d Beta (SE)	P-value	Model 3 Beta (SE)	P-value
Beck Depression Inventory score	−0.40 (0.17)	0.02	−0.38 (0.17)	0.03	−0.32 (0.17)	0.07	−0.49 (0.18)	0.007	−0.41 (0.20)	0.04	−0.42 (0.20)	0.04
Number of role transitions	-	-	−3.43 (1.38)	0.01	-	-	-	-	-	-	−3.32 (1.38)	0.02
Interpersonal conflict	-	-	-	-	−3.65 (1.74)	0.04	-	-	-	-	−3.78 (1.74)	0.03
Dysfunctional attitudes	-	-	-	-	-	-	0.10 (0.07)	0.17	-	-	0.12 (0.07)	0.08
Lack of pleasant events	-	-	-	-	-	-	-	-	0.61 (7.02)	0.93	1.67 (6.91)	0.81

Abbreviations: SE, Standard Error

^*All models were additionally adjusted for age, gender, race, partner status, and Charlson score; none of these covariates were significantly associated with aspirin adherence (all P>0.1).

Model 1 tests the extent to which depressive symptoms predicted aspirin adherence in the 3 months after hospitalization for an acute coronary syndrome; adjusted R² = 0.03.

Models 2a – 2d test the extent to which depressive symptoms predicted aspirin adherence in the 3 months after hospitalization for an acute coronary syndrome after accounting for each depression vulnerability, individually.

Model 3 tests the extent to which depressive symptoms predicted aspirin adherence in the 3 months after hospitalization for an acute coronary syndrome after accounting for all of the depression vulnerabilities concurrently; adjusted R² = 0.08.